Pharmaceutical compound
Clinical data | |
---|---|
Other names | 4-(4-Ethylphenyl)piperidine |
Drug class | Antidepressant |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H19N |
Molar mass | 189.302 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Enefexine (INNTooltip International Nonproprietary Name), also known as 4-(4-ethylphenyl)piperidine, is a drug of the phenylpiperidine group which is described as an antidepressant but was never marketed. It was first described in the literature by 1983. The drug was developed by Ciba-Geigy.
See also
References
- ^ Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 519. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
- Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (PDF). World Health Organization. 2024. p. 100. ISBN 978-92-4-009938-8.
- ^ CH 634298, Georges H, Alberto R, Giorgio FP, Oswald S, "Process for preparing phenylazacycloalkanes", published 31 January 1983, assigned to Ciba Geigy AG
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |